Augmented phosphoinositide metabolism in aortas from genetically hypertensive rats

M. B. Turla, R. C. Webb

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Recent studies suggest that serotonergic receptor activation is coupled to phospholipase C-mediated phosphoinositide hydrolysis, which results in the release of intracellular second messengers. The purpose of this study was to determine whether altered phosphoinositide metabolism is the basis for augmented vascular responsiveness to serotonin in genetic hypertension. Thoracic aortic segments isolated from stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto normotensive rats (WKY) were labeled with myo-[3H]-inositol and stimulated with serotonin in the presence of LiCl. Accumulation of [3H]inositol phosphates was then quantitated by column chromatography. Basal inositol phosphate accumulation and basal incorporation of myo-[3H]inositol into aortic cell membranes from SHRSP was not significantly different from WKY values. At 2.6 x 10-7 to 2.6 x 10-4 M serotonin, phosphoinositide metabolism was significantly augmented in aortae from SHRSP compared with WKY. Depolarization (100 mM KCl) did not increase phosphoinositide hydrolysis above basal levels in SHRSP or WKY. 2-Nitro-4-carboxyphenyl-N, N-diphenyl carbamate (NCDC), an inhibitor of phospholipase C, prevented the serotonin-induced phosphoinositide metabolism. NCDC also partially inhibited phasic contractions (responses in calcium-free solution) to serotonin in aortas from SHRSP and WKY. In conclusion, abnormal phosphoinositide metabolism may be one mechanism responsible for the characteristic increase in vascular reactivity to serotonin in hypertension.

Original languageEnglish (US)
Pages (from-to)H173-H178
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume258
Issue number1 27-1
StatePublished - Jan 1 1990

Fingerprint

Phosphatidylinositols
Aorta
Serotonin
Inositol Phosphates
Carbamates
Inositol
Blood Vessels
Hydrolysis
Hypertension
Phosphoinositide Phospholipase C
Inbred WKY Rats
Type C Phospholipases
Second Messenger Systems
Inbred SHR Rats
Chromatography
Thorax
Stroke
Cell Membrane
Calcium

Keywords

  • 5-hydroxytryptamine
  • Phosphatidylinositol hydrolysis
  • Phospholipase C
  • Stroke-prone spontaneously hypertensive rats
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Augmented phosphoinositide metabolism in aortas from genetically hypertensive rats. / Turla, M. B.; Webb, R. C.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 258, No. 1 27-1, 01.01.1990, p. H173-H178.

Research output: Contribution to journalArticle

@article{3e2fbbe522584b72951aed28e879dd33,
title = "Augmented phosphoinositide metabolism in aortas from genetically hypertensive rats",
abstract = "Recent studies suggest that serotonergic receptor activation is coupled to phospholipase C-mediated phosphoinositide hydrolysis, which results in the release of intracellular second messengers. The purpose of this study was to determine whether altered phosphoinositide metabolism is the basis for augmented vascular responsiveness to serotonin in genetic hypertension. Thoracic aortic segments isolated from stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto normotensive rats (WKY) were labeled with myo-[3H]-inositol and stimulated with serotonin in the presence of LiCl. Accumulation of [3H]inositol phosphates was then quantitated by column chromatography. Basal inositol phosphate accumulation and basal incorporation of myo-[3H]inositol into aortic cell membranes from SHRSP was not significantly different from WKY values. At 2.6 x 10-7 to 2.6 x 10-4 M serotonin, phosphoinositide metabolism was significantly augmented in aortae from SHRSP compared with WKY. Depolarization (100 mM KCl) did not increase phosphoinositide hydrolysis above basal levels in SHRSP or WKY. 2-Nitro-4-carboxyphenyl-N, N-diphenyl carbamate (NCDC), an inhibitor of phospholipase C, prevented the serotonin-induced phosphoinositide metabolism. NCDC also partially inhibited phasic contractions (responses in calcium-free solution) to serotonin in aortas from SHRSP and WKY. In conclusion, abnormal phosphoinositide metabolism may be one mechanism responsible for the characteristic increase in vascular reactivity to serotonin in hypertension.",
keywords = "5-hydroxytryptamine, Phosphatidylinositol hydrolysis, Phospholipase C, Stroke-prone spontaneously hypertensive rats, Vascular smooth muscle",
author = "Turla, {M. B.} and Webb, {R. C.}",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "258",
pages = "H173--H178",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 27-1",

}

TY - JOUR

T1 - Augmented phosphoinositide metabolism in aortas from genetically hypertensive rats

AU - Turla, M. B.

AU - Webb, R. C.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Recent studies suggest that serotonergic receptor activation is coupled to phospholipase C-mediated phosphoinositide hydrolysis, which results in the release of intracellular second messengers. The purpose of this study was to determine whether altered phosphoinositide metabolism is the basis for augmented vascular responsiveness to serotonin in genetic hypertension. Thoracic aortic segments isolated from stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto normotensive rats (WKY) were labeled with myo-[3H]-inositol and stimulated with serotonin in the presence of LiCl. Accumulation of [3H]inositol phosphates was then quantitated by column chromatography. Basal inositol phosphate accumulation and basal incorporation of myo-[3H]inositol into aortic cell membranes from SHRSP was not significantly different from WKY values. At 2.6 x 10-7 to 2.6 x 10-4 M serotonin, phosphoinositide metabolism was significantly augmented in aortae from SHRSP compared with WKY. Depolarization (100 mM KCl) did not increase phosphoinositide hydrolysis above basal levels in SHRSP or WKY. 2-Nitro-4-carboxyphenyl-N, N-diphenyl carbamate (NCDC), an inhibitor of phospholipase C, prevented the serotonin-induced phosphoinositide metabolism. NCDC also partially inhibited phasic contractions (responses in calcium-free solution) to serotonin in aortas from SHRSP and WKY. In conclusion, abnormal phosphoinositide metabolism may be one mechanism responsible for the characteristic increase in vascular reactivity to serotonin in hypertension.

AB - Recent studies suggest that serotonergic receptor activation is coupled to phospholipase C-mediated phosphoinositide hydrolysis, which results in the release of intracellular second messengers. The purpose of this study was to determine whether altered phosphoinositide metabolism is the basis for augmented vascular responsiveness to serotonin in genetic hypertension. Thoracic aortic segments isolated from stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto normotensive rats (WKY) were labeled with myo-[3H]-inositol and stimulated with serotonin in the presence of LiCl. Accumulation of [3H]inositol phosphates was then quantitated by column chromatography. Basal inositol phosphate accumulation and basal incorporation of myo-[3H]inositol into aortic cell membranes from SHRSP was not significantly different from WKY values. At 2.6 x 10-7 to 2.6 x 10-4 M serotonin, phosphoinositide metabolism was significantly augmented in aortae from SHRSP compared with WKY. Depolarization (100 mM KCl) did not increase phosphoinositide hydrolysis above basal levels in SHRSP or WKY. 2-Nitro-4-carboxyphenyl-N, N-diphenyl carbamate (NCDC), an inhibitor of phospholipase C, prevented the serotonin-induced phosphoinositide metabolism. NCDC also partially inhibited phasic contractions (responses in calcium-free solution) to serotonin in aortas from SHRSP and WKY. In conclusion, abnormal phosphoinositide metabolism may be one mechanism responsible for the characteristic increase in vascular reactivity to serotonin in hypertension.

KW - 5-hydroxytryptamine

KW - Phosphatidylinositol hydrolysis

KW - Phospholipase C

KW - Stroke-prone spontaneously hypertensive rats

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=0025169921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025169921&partnerID=8YFLogxK

M3 - Article

C2 - 2154130

AN - SCOPUS:0025169921

VL - 258

SP - H173-H178

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1 27-1

ER -